We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test’s ability to predict how well bladder cancer patients will respond to therapy allows for “timely interventions that could result in more favorable outcomes,” the company said. Read More
This sort of action against CROs is something rarely seen from the FDA; the last occurrence was in April 2016 and involved another Indian CRO, Semler Research. Read More
The device offers a minimally invasive local microsurgery procedure to deal with the cyst that causes the condition and to restore patient brain function and development. Read More
The system “allows simplified delivery of a wide range of allograft and autograft products, including viscous and fibrous materials,” the company says. Read More